Potential use of artificial nose in diagnosis and monitoring of different lung diseases

I. Taivans, U. Kopeika, M. Bukovskis, N. Jurka, J. Kleperis, V. Ogorodniks (Riga, Latvia)

Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Session: Diagnosis and prognosis in thoracic oncology
Session type: Electronic Poster Discussion
Number: 3196
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Taivans, U. Kopeika, M. Bukovskis, N. Jurka, J. Kleperis, V. Ogorodniks (Riga, Latvia). Potential use of artificial nose in diagnosis and monitoring of different lung diseases. Eur Respir J 2007; 30: Suppl. 51, 3196

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Overview and history of different ways of assessing and monitoring inflammatory airway diseases
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017


Fine crackles quantitative value can help the diagnosis of interstitial lung diseases – Clinical utility of the innovative analyzing system of respiratory sounds
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019

The electronic nose: emerging biomarkers in lung cancer diagnostics
Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019
Year: 2019



Noninvasive assessment in the evaluation of occupational lung diseases
Source: Annual Congress 2009 - MP8 - Noninvasive assessment in the evaluation of occupational lung diseases
Year: 2009


Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


The evolution of respiratory function testing in paediatric lung diseases
Source: Virtual Congress 2020 – Lung health and respiratory function at all ages
Year: 2020


Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


Can AI help in detecting respiratory diseases with incomplete lung function data?
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021


Optimising disease models for lung diseases and drug development
Source: International Congress 2015 – Development and application of new approaches for respiratory disease research
Year: 2015



Diagnosis of interstitial lung diseases using eNose technology
Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Year: 2020




Detecting lung infections in breathprints: empty promise or next generation diagnosis of infections
Source: Eur Respir J 2015; 45: 21-24
Year: 2015


Evidence base of lung function indices in diagnosis and follow-up of chronic respiratory diseases in primary care
Source: Annual Congress 2012 - Primary Care Programme
Year: 2012

Home monitoring of patients with chronic lung diseases using wireless devices
Source: Eur Respir J 2005; 26: Suppl. 49, 297s
Year: 2005

Assessing & monitoring airway diseases using lung function
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019



Current challenges in diagnosing and treating adults with interstitial lung disease
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014




Monitoring of early lung disease: Is it clinically important to do routine infant lung function test?
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004